Published in Comp Med on February 01, 2008
Generation of a specific-pathogen-free baboon colony. J Am Assoc Lab Anim Sci (2010) 0.93
Meeting report: Spontaneous lesions and diseases in wild, captive-bred, and zoo-housed nonhuman primates and in nonhuman primate species used in drug safety studies. Vet Pathol (2012) 0.85
Rhesus lymphocryptovirus type 1-associated B-cell nasal lymphoma in SIV-infected rhesus macaques. Vet Pathol (2008) 0.84
Proceedings of the 2011 National Toxicology Program Satellite Symposium. Toxicol Pathol (2011) 0.82
CD4+ and CD8+ T-cell responses to latent antigen EBNA-1 and lytic antigen BZLF-1 during persistent lymphocryptovirus infection of rhesus macaques. J Virol (2013) 0.79
Condylomatous genital lesions in cynomolgus macaques from Mauritius. Toxicol Pathol (2012) 0.75
Hypergammaglobulinemia in an SIV-infected rhesus macaque with a B-cell neoplasm with plasma cell differentiation. J Med Primatol (2011) 0.75
Adenocarcinoma of the ileocolic junction and multifocal hepatic sarcomas in an aged rhesus macaque (Macaca mulatta). Comp Med (2013) 0.75
Post-transplant lymphoproliferative disorder associated with immunosuppressive therapy for renal transplantation in rhesus macaques (Macaca mulatta). Exp Toxicol Pathol (2013) 0.75
Mountain gorilla lymphocryptovirus has Epstein-Barr virus-like epidemiology and pathology in infants. Sci Rep (2017) 0.75
VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. Lancet (1964) 14.21
Epstein-Barr virus: 40 years on. Nat Rev Cancer (2004) 9.70
The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature (1998) 4.47
Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol (2007) 4.14
Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol (2002) 3.52
Epstein-Barr virus and virus human protein interaction maps. Proc Natl Acad Sci U S A (2007) 3.50
Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells. Proc Natl Acad Sci U S A (1975) 3.26
The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells. J Virol (1995) 3.16
The family Herpesviridae: an update. The Herpesvirus Study Group of the International Committee on Taxonomy of Viruses. Arch Virol (1992) 3.09
Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J Virol (1992) 2.83
EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus. Rev Med Virol (2000) 2.12
Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol (2005) 1.99
What is Burkitt's lymphoma and when is it endemic? Blood (1999) 1.97
Complete nucleotide sequence of the rhesus lymphocryptovirus: genetic validation for an Epstein-Barr virus animal model. J Virol (2002) 1.87
An animal model for acute and persistent Epstein-Barr virus infection. Science (1997) 1.85
CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator. Oncogene (1996) 1.85
A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates. J Exp Med (2007) 1.70
Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proc Natl Acad Sci U S A (2006) 1.70
Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies. Int J Cancer (1974) 1.62
Lytic cycle switches of oncogenic human gammaherpesviruses. Adv Cancer Res (2007) 1.57
Complete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a new world primate: a defining point in the evolution of oncogenic lymphocryptoviruses. J Virol (2002) 1.50
Treatment of post-transplant lymphoproliferative disease with rituximab monoclonal antibody after lung transplantation. Lancet (1999) 1.46
Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses. J Virol (2000) 1.46
Latent and lytic Epstein-Barr virus replication strategies. Rev Med Virol (2004) 1.45
Simian homologues of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci (2001) 1.40
Pediatric lymphocytic interstitial pneumonitis in an HIV-negative child with pulmonary Epstein-Barr virus infection. Pediatr Pulmonol (2003) 1.40
Epstein-Barr virus-related herpesvirus from a rhesus monkey (Macaca mulatta) with malignant lymphoma. Int J Cancer (1986) 1.38
Antibodies to LMP2A/2B in EBV-carrying malignancies. Eur J Cancer (1995) 1.37
Treatment of PTLD with rituximab or chemotherapy. Am J Transplant (2006) 1.33
Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host. Blood (2004) 1.32
Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD). Am J Transplant (2005) 1.26
Infection of human B lymphocytes with lymphocryptoviruses related to Epstein-Barr virus. J Virol (1998) 1.23
Evolution of two types of rhesus lymphocryptovirus similar to type 1 and type 2 Epstein-Barr virus. J Virol (1999) 1.15
Cloning of the rhesus lymphocryptovirus viral capsid antigen and Epstein-Barr virus-encoded small RNA homologues and use in diagnosis of acute and persistent infections. J Clin Microbiol (2000) 1.14
Infectious mononucleosis and Epstein-Barr virus. Expert Rev Mol Med (2004) 1.12
Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus. J Virol (2000) 1.10
Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management. Leuk Lymphoma (1995) 1.10
Epstein-Barr virus latent and replicative gene expression in oral hairy leukoplakia. Histopathology (1992) 1.04
Herpes simplex virus and Epstein-Barr virus infections in pregnancy: consequences of neonatal or intrauterine infection. Reprod Toxicol (2005) 1.03
Burkitt's lymphoma in adults with and without human immunodeficiency virus infection: a single-institution clinicopathologic study of 75 patients. Cancer (1998) 1.03
Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation. Nephrology (Carlton) (2006) 1.02
Epstein-Barr virus (EBV)-encoded RNA 2 (EBER2) but not EBER1 plays a critical role in EBV-induced B-cell growth transformation. J Virol (2007) 1.00
Immunological aspects of Epstein-Barr virus infection. Crit Rev Oncol Hematol (2002) 0.99
The latent membrane protein 1 of Epstein-Barr virus (EBV) primes EBV latency cells for type I interferon production. J Biol Chem (2006) 0.99
Strong selective pressure for evolution of an Epstein-Barr virus LMP2B homologue in the rhesus lymphocryptovirus. J Virol (1999) 0.98
Evidence for a relation of Epstein-Barr virus to Burkitt's lymphoma and nasopharyngeal carcinoma. Bibl Haematol (1970) 0.98
The BZLF1 homolog of an Epstein-Barr-related gamma-herpesvirus is a frequent target of the CTL response in persistently infected rhesus macaques. J Immunol (2006) 0.96
The CD8+ T-cell response to an Epstein-Barr virus-related gammaherpesvirus infecting rhesus macaques provides evidence for immune evasion by the EBNA-1 homologue. J Virol (2005) 0.95
Fatal lymphoproliferative disease associated with a novel gammaherpesvirus in a captive population of common marmosets. Comp Med (2000) 0.94
Epstein-Barr virus (EBV)-induced lymphoproliferative disease in cotton-topped marmosets. Int J Cancer (1983) 0.94
Different Epstein-Barr virus expression in lymphomas from immunocompromised and immunocompetent patients. Am J Pathol (1990) 0.93
Phylogenetic relationships in the Lymphocryptovirus genus of the Gammaherpesvirinae. Virus Res (2004) 0.93
Malignant lymphoma in the X-linked lymphoproliferative syndrome. Cancer (1987) 0.92
Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma: association with diffuse large-cell subtype. Blood (1994) 0.92
Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD. Transpl Immunol (2006) 0.92
Squamous epithelial proliferative lesions associated with rhesus Epstein-Barr virus in simian immunodeficiency virus-infected rhesus monkeys. J Infect Dis (1995) 0.90
Rhesus lymphocryptovirus infection during the progression of SAIDS and SAIDS-associated lymphoma in the rhesus macaque. AIDS Res Hum Retroviruses (2000) 0.90
SIV-associated lymphomas in rhesus monkeys (Macaca mulatta) in comparison with HIV-associated lymphomas. Vet Pathol (2002) 0.89
Molecular evidence for rhesus lymphocryptovirus infection of epithelial cells in immunosuppressed rhesus macaques. J Virol (2004) 0.89
Characterization of four herpesviruses isolated from owl monkeys and their comparison with Herpesvirus saimiri type 1 (Herpesvirus tamarinus) and herpes simplex virus type 1. J Comp Pathol (1987) 0.88
Characterization of an Epstein-Barr virus-related gammaherpesvirus from common marmoset (Callithrix jacchus). J Gen Virol (2002) 0.87
Posttransplant lymphoproliferative disorder associated with an Epstein-Barr-related virus in cynomolgus monkeys. Transplantation (2002) 0.87
AIDS-related non-Hodgkin's lymphomas. Microsc Res Tech (2005) 0.87
Epstein-Barr virus and Hodgkin's lymphoma. Herpes (2006) 0.87
The relationship of Epstein-Barr virus to infection-related (sporadic) and familial hemophagocytic syndrome and secondary (lymphoma-related) hemophagocytosis: an in situ hybridization study. Hum Pathol (1993) 0.87
Severe Epstein-Barr virus-associated hemophagocytic syndrome in six adult patients. J Clin Virol (2007) 0.86
Detection of Epstein-Barr virus small RNAs EBER1 and EBER2 in lymphomas of SIV-infected rhesus monkeys by in situ hybridization. Int J Cancer (1997) 0.84
Identifying gp85-regions involved in Epstein-Barr virus binding to B-lymphocytes. Biochem Biophys Res Commun (2004) 0.84
Reduced prevalence of Epstein-Barr virus-related lymphocryptovirus infection in sera from a new world primate. J Virol (2005) 0.84
Comparative pathobiology of Kaposi sarcoma-associated herpesvirus and related primate rhadinoviruses. Comp Med (2008) 0.84
Compatibility of the gH homologues of Epstein-Barr virus and related lymphocryptoviruses. J Gen Virol (2007) 0.84
Growth regulation of simian and human AIDS-related non-Hodgkin's lymphoma cell lines by TGF-beta1 and IL-6. BMC Cancer (2007) 0.83
Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course. Ann Hematol (2006) 0.83
A novel Epstein-Barr virus-like virus, HV(MNE), in a Macaca nemestrina with mycosis fungoides. Blood (1999) 0.82
Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques. J Med Virol (2001) 0.82
The Epstein-Barr Virus (EBV) in Burkitt's lymphoma and nasopharyngeal carcinoma. Ann Clin Lab Sci (1974) 0.81
Gamma herpesviruses: pathogenesis of infection and cell signaling. Folia Microbiol (Praha) (2003) 0.81
LMP-1, the Epstein-Barr virus-encoded oncogene with a B cell activating mechanism similar to CD40. Immunol Lett (1999) 0.81
An Overview of Epstein-Barr Virus: from Discovery to Future Directions for Treatment and Prevention. Herpes (2000) 0.80
Epstein-Barr virus and HIV-AIDS-associated diseases. Biomed Pharmacother (2001) 0.79
Comparative pathobiology of HIV- and SIV-associated lymphoma. AIDS Res Hum Retroviruses (2001) 0.79
Epstein-Barr virus, malaria and Burkitt's lymphoma. Scand J Infect Dis Suppl (1982) 0.79
Induction of lymphoma in owl monkeys with heated, non-cytopathogenic Herpesvirus saimiri. Nat New Biol (1973) 0.79
Characterization of macromolecular lignins as Epstein-Barr virus inducer in foodstuff associated with nasopharyngeal carcinoma risk. Carcinogenesis (1995) 0.78
Malignant NK/T-cell lymphoma associated with simian Epstein-Barr virus infection in a Japanese macaque (Macaca fuscata). Exp Anim (2005) 0.78
HV(MNE), a novel lymphocryptovirus related to Epstein-Barr virus, induces lymphoma in New Zealand White rabbits. Blood (2001) 0.77
Constitutive activation of oncogenes by chromosomal translocations in B-cell derived tumors. AIDS Res (1986) 0.77
The owl monkey (Aotus trivirgatus) as an animal model for viral diseases and oncologic studies. Lab Anim Sci (1976) 0.77
Retrospective analysis of clinical and laboratory factors associated with lymphoma in simian AIDS. Leuk Lymphoma (2004) 0.76
Hairy leukoplakia, EBV: an oral history of AIDS. Dent Today (1989) 0.76
Sites of Epstein-Barr virus replication in acute and chronic active Epstein-Barr virus infections. Intervirology (1989) 0.76
Hairy leucoplakia and HIV-2--a case report and review of the literature. Clin Exp Dermatol (1994) 0.76
Epstein-Barr virus-associated lymphomas. Expert Rev Anti Infect Ther (2006) 0.76
Oral hairy leukoplakia in an HIV-seronegative heart transplant patient. J Oral Pathol Med (1990) 0.76
Lymphoma induction and viral isolation from owl monkey (Aotus trivirgatus) inoculated with lymphoma cells induced by Herpesvirus saimiri. Am J Vet Res (1973) 0.76
Burkitt's lymphoma, nasopharyngeal carcinoma, infectious mononucleosis and the Epstein-Barr virus. Laryngoscope (1972) 0.76
Epstein-Barr virus-associated antigens in nasopharyngeal carcinoma. Arch Otolaryngol (1978) 0.75
Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature (2008) 6.17
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys. Nature (2012) 5.49
Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity. Nature (2006) 4.59
Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D. J Virol (2007) 4.54
Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys. Nat Med (2010) 3.44
Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeys. J Virol (2008) 2.66
Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants. Nat Immunol (2005) 2.60
Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys. Nat Med (2010) 2.53
Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys. J Virol (2010) 2.39
Trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccination. J Immunol (2008) 2.35
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations. Vaccine (2011) 1.88
Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys. J Virol (2005) 1.65
ADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challenge. PLoS Pathog (2012) 1.60
Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system. J Virol (2003) 1.60
Impact of Nef-mediated downregulation of major histocompatibility complex class I on immune response to simian immunodeficiency virus. J Virol (2004) 1.49
The marmoset as a model of aging and age-related diseases. ILAR J (2011) 1.43
Circulating Nef induces dyslipidemia in simian immunodeficiency virus-infected macaques by suppressing cholesterol efflux. J Infect Dis (2010) 1.34
Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates. PLoS Negl Trop Dis (2012) 1.32
Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates. J Immunol (2004) 1.28
Durable mucosal simian immunodeficiency virus-specific effector memory T lymphocyte responses elicited by recombinant adenovirus vectors in rhesus monkeys. J Virol (2011) 1.27
A second Aggregatibacter actinomycetemcomitans autotransporter adhesin exhibits specificity for buccal epithelial cells in humans and Old World primates. Infect Immun (2007) 1.24
Phenotypic variation in myocardial macrophage populations suggests a role for macrophage activation in SIV-associated cardiac disease. AIDS Res Hum Retroviruses (2007) 1.21
Mucosal trafficking of vector-specific CD4+ T lymphocytes following vaccination of rhesus monkeys with adenovirus serotype 5. J Virol (2010) 1.16
Role of CD8(+) lymphocytes in control and clearance of measles virus infection of rhesus monkeys. J Virol (2003) 1.15
Immunization with single-cycle SIV significantly reduces viral loads after an intravenous challenge with SIV(mac)239. PLoS Pathog (2009) 1.12
SIV-associated myocarditis: viral and cellular correlates of inflammation severity. AIDS Res Hum Retroviruses (2006) 1.09
Potent simian immunodeficiency virus-specific cellular immune responses in the breast milk of simian immunodeficiency virus-infected, lactating rhesus monkeys. J Immunol (2008) 1.09
High-performance metabolic profiling of plasma from seven mammalian species for simultaneous environmental chemical surveillance and bioeffect monitoring. Toxicology (2012) 1.08
Limited contribution of humoral immunity to the clearance of measles viremia in rhesus monkeys. J Infect Dis (2004) 1.07
GB virus B infection of the common marmoset (Callithrix jacchus) and associated liver pathology. J Gen Virol (2004) 1.07
Non-human primate model of Kaposi's sarcoma-associated herpesvirus infection. PLoS Pathog (2009) 1.06
Differential contribution of dietary fat and monosaccharide to metabolic syndrome in the common marmoset (Callithrix jacchus). Obesity (Silver Spring) (2010) 1.01
Local replication of simian immunodeficiency virus in the breast milk compartment of chronically-infected, lactating rhesus monkeys. Retrovirology (2010) 0.96
Reproductive output, maternal age, and survivorship in captive common marmoset females (Callithrix jacchus). Am J Primatol (2004) 0.96
Vaccine protection against simian immunodeficiency virus in monkeys using recombinant gamma-2 herpesvirus. J Virol (2011) 0.91
Alterations in expression of monocyte chemotactic protein-1 in the simian immunodeficiency virus model of disseminated Mycobacterium avium complex. J Infect Dis (2004) 0.91
Interleukin-18 predicts atherosclerosis progression in SIV-infected and uninfected rhesus monkeys (Macaca mulatta) on a high-fat/high-cholesterol diet. Lab Invest (2009) 0.91
Quantitative molecular assessment of chimerism across tissues in marmosets and tamarins. BMC Genomics (2012) 0.90
Overview of known non-human primate pathogens with potential to affect colonies used for toxicity testing. J Immunotoxicol (2010) 0.90
Differential expression of GLUT2 in pancreatic islets and kidneys of New and Old World nonhuman primates. Am J Physiol Regul Integr Comp Physiol (2008) 0.90
DNA-MVA vaccine protection after X4 SHIV challenge in macaques correlates with day-of-challenge antiviral CD4+ cell-mediated immunity levels and postchallenge preservation of CD4+ T cell memory. AIDS Res Hum Retroviruses (2008) 0.90
Colonization with nontuberculous mycobacteria is associated with positive tuberculin skin test reactions in the common marmoset (Callithrix jacchus). Comp Med (2011) 0.88
Introduction: challenges in microbial quality control for nonhuman primate. ILAR J (2008) 0.87
Antigenic stimulation in the simian model of HIV infection yields dilated cardiomyopathy through effects of TNFalpha. AIDS (2008) 0.86
Glycoprotein gene sequence variation in rhesus monkey rhadinovirus. Virology (2010) 0.86
Extended safety and efficacy studies of a live attenuated double leucine and pantothenate auxotroph of Mycobacterium tuberculosis as a vaccine candidate. Vaccine (2011) 0.86
Psychogenic alopecia in rhesus macaques presenting as focally extensive alopecia of the distal limb. Comp Med (2011) 0.85
Cerebral amyloid-beta protein accumulation with aging in cotton-top tamarins: a model of early Alzheimer's disease? Rejuvenation Res (2008) 0.85
Patterns of acute rhesus cytomegalovirus (RhCMV) infection predict long-term RhCMV infection. J Virol (2012) 0.85
Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switching. Proc Natl Acad Sci U S A (2008) 0.84
Frequent infection of neurons by SV40 virus in SIV-infected macaque monkeys with progressive multifocal leukoencephalopathy and meningoencephalitis. Am J Pathol (2013) 0.84
Comparative pathobiology of Kaposi sarcoma-associated herpesvirus and related primate rhadinoviruses. Comp Med (2008) 0.84
Envelope-modified single-cycle simian immunodeficiency virus selectively enhances antibody responses and partially protects against repeated, low-dose vaginal challenge. J Virol (2010) 0.84
SIRPα/CD172a and FHOD1 are unique markers of littoral cells, a recently evolved major cell population of red pulp of human spleen. J Immunol (2012) 0.84
Wasting syndrome and disruption of the somatotropic axis in simian immunodeficiency virus-infected macaques with Mycobacterium avium complex infection. J Infect Dis (2004) 0.83
Workshop summary: neotropical primates in biomedical research. ILAR J (2011) 0.82
Preservation of memory CD4(+) T lymphocytes in breast milk of lactating rhesus monkeys during acute simian immunodeficiency virus infection. J Infect Dis (2010) 0.81
Body-composition changes in the simian immunodeficiency virus-infected juvenile rhesus macaque. J Infect Dis (2004) 0.80
Immunophenotypic alterations in resident immune cells and myocardial fibrosis in the aging rhesus macaque (Macaca mulatta) heart. Toxicol Pathol (2012) 0.79
Clinical monitoring and correlates of nephropathy in SIV-infected macaques during high-dose antiretroviral therapy. AIDS Res Ther (2011) 0.79
Oral papillomas and papilliform lesions in rhesus macaques (Macaca mulatta). Comp Med (2005) 0.79
Opportunistic infections in immunologically compromised nonhuman primates. ILAR J (2008) 0.79
Naturally occurring Tyzzer's disease in cotton-top tamarins (Saguinus oedipus). Comp Med (2007) 0.77
Treatment of giardiasis in common marmosets (Callithrix jacchus) with tinidazole. Comp Med (2009) 0.76
Hypergammaglobulinemia in an SIV-infected rhesus macaque with a B-cell neoplasm with plasma cell differentiation. J Med Primatol (2011) 0.75
Naturally occurring infections in non-human primates (NHP) and immunotoxicity implications: discussion sessions. J Immunotoxicol (2010) 0.75